Doctors analyzed people with AFib who have a stroke at some point in their lives and they found distinct trends. While simply having AFib raises your chances of getting a stroke, there are several ...

What is aFib? As the heart pumps blood through the body, it needs to do it with a regular beat. However, when the timer that ...

If you have severe AFib symptoms, you'll get these medicines through an IV in a hospital. You might take calcium channel blockers on their own or with other rate control medicines to help them ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% CI 0.61-1.03), noted Varun Sundaram, MD, PhD, MSc, of Case Western ...

Heart failure: A weakened heart muscle can struggle to maintain a normal rhythm, leading to AFib. How AFib can affect your ...

Fire up the ECG app, pop your finger on the crown, and you’ll be guided through the reading. You’ll be notified whether the reading is regular or shows signs of atrial fibrillation, and an EKG ...

ANSWER: AFib, an irregular and often fast heart rhythm, is common and has several well-known risk factors that precipitate an event. The ER will have considered several of these, including thyroid ...

Ascension St. Vincent’s Riverside is pioneering pulsed field ablation, a non-thermal treatment for atrial fibrillation (AFib). This new technique offers a safer and faster alternative to ...

Until 2016, people diagnosed with atrial fibrillation had no alternatives other than taking blood thinners to prevent a stroke. But In 2016, the FDA approved a left atrial appendage closure device.

Researchers at Northwestern Medicine plan to give Apple Watches to thousands of people as part of a health study. The study is geared toward patients with atrial fibrillation, or AFib, the most ...

Apple Watch user discovers A-fib heart issue with new ECG app, ‘this probably saved you,’ says doctor Apple Watch proves to be a lifesaver for 70-year-old Arizona woman ...

With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the fast-growing sector for “pulsed field” AFib treatments.